Special Issue "COVID-19—Advances in Clinical and Epidemiological Aspects"
Deadline for manuscript submissions: closed (30 September 2021).
Interests: systemic autoimmune diseases; immune-related viral disorders; internal medicine; COVID-19
Interests: Clinic Research; COVID-19; autoimmune diseases
Special Issues and Collections in MDPI journals
Severe acute respiratory syndrome 2 coronavirus (SARS-CoV-2), first detected in December 2019 in Wuhan, China, is the seventh coronavirus known to infect humans after the identification, in this century, of SARS and Middle East Respiratory Syndrome (MERS) viruses. The lack of pre-virus immunity has led to an exponential increase in infected patients worldwide and the pandemic is one of the biggest health challenges facing humanity in the last 100 years.
The COVID-19 pandemic disrupted science in 2020. Around 4% of the world’s research output was devoted to SARS-CoV-2 in 2020, according to one database, and around 6% of those indexed in PubMed, which mostly covers life sciences, were dedicated to the topic. Scientists published well over 200,000 articles about the coronavirus pandemic in 2020.
In this scenario of overproduction, our goal is to develop a very specific collection of articles especially focused on clinical and epidemiological aspects that have disrupted previous knowledge on the complex interplay between viruses and human disease. Therefore, we are especially interested in, but not limited to, receiving manuscripts on the following topics:
- Epidemiology of SARS-CoV-2
- Influence of ethnicity, sex and geolocation in phenotypic expression of COVID-19
- Impact of external conditions of COVID-19 outbreak
- Exposome and viral infection
- Immune-related features of COVID-19
- COVID-19 in autoimmune and immune-mediated populations (rheumatic, systemic, organ-specific)
- Diagnosis and infection monitoring strategies
- Immunosuppressants and biological agents, friends or foes?
- Primary care
- Outpatient management
- Population-based studies
- Big data-driven COVID-19 research
- Machine learning, Deep learning and Network science for COVID-19;
- Risk assessment for enhanced surveillance
- Patient’s experience
- Electronic and digital health-related services
We welcome the submission of reviews, original research articles, short communications, systematic reviews, and case studies. High-quality submissions will be considered for a publication cost discount after completion of the manuscript review process, as recommended by the Editorial Board.
Editorial Board Members of the SI:
Prof. Roberto Giacomelli (Rome, Italy)
Prof. Damien Sène (Paris, France)
Prof. Hendrik Schulze-Koops (Munich, Germany)
Prof. Tanja Stamm (Vienna, Austria)
Dr. Francesco Carubbi (L’Aquila, Italy)
Prof. Pilar Brito-Zerón (Barcelona, Spain)
Dr. Gabriela Hernández-Molina (Mexico DF, Mexico)
Prof. Soledad Retamozo (Córdoba, Argentina)
Prof. Jesús Canora-Lebrato (Madrid, Spain)
Prof. Dr. Manuel Ramos-Casals
Prof. Dr. Antoni Sisó-Almirall
Prof. Dr. Luca Quartuccio
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- phenotypic expression
- immune-related features
- autoimmune populations
- rheumatic diseases
- systemic autoimmune diseases
- organ-specific autoimmune diseases
- monitoring strategies
- biological agents
- primary care
- population-based studies
- big data
- machine learning
- deep learning
- network science